Startseite Indirect method for validating transference of reference intervals
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Indirect method for validating transference of reference intervals

  • Simon Lykkeboe , Claus Gyrup Nielsen und Peter Astrup Christensen EMAIL logo
Veröffentlicht/Copyright: 14. Oktober 2017
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background:

Transference of reference intervals (RIs) from multicentre studies are often verified by use of a small number of samples from reference individuals or by the use of one serum sample (Serum X for NORIP RI). Despite recommended and appropriate methods, both have inconveniencies and drawbacks. Several attempts have been made to develop an indirect method, which uses historical data from the laboratory. These methods are retrospective relying on older test results. A near prospective method would be preferable for the laboratories introducing new methods or changing analytical platforms.

Methods:

We performed a data mining experiment using results from our laboratory information system covering patients from a large geographic area. Request patterns for patients with assumed healthy characteristics were identified and used to extract laboratory results for calculation of new RI by an indirect method. Calculated RI and confidence intervals (CIs) were compared to transferred NORIP RI verified by NFKK Reference Serum X.

Results:

We found that our indirect method and NFKK Reference Serum X in general produced similar results when verifying transference of RI. The method produces results for all stratifications. Only single stratifications and one analyte showed unexplained incongruences to the NORIP RI.

Conclusions:

Our results suggest using request patterns as a surrogate measure for good health status. This allows for a data mining method for validation of RI or validating their transference, which is likely to be applicable in countries with similar healthcare and laboratory information system.

Acknowledgments

The authors thank the staff at the Department of Clinical Biochemistry, Aalborg University Hospital, for valuable discussions and Professor Aase Handberg for critical reading of the manuscript.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organisation(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Ceriotti F, Hinzmann R, Panteghini M. Reference intervals: the way forward. Ann Clin Biochem 2009;46:8–17.10.1258/acb.2008.008170Suche in Google Scholar

2. Horn PS, Pesce AJ. Reference intervals: an update. Clin Chim Acta 2003;334:5–23.10.1016/S0009-8981(03)00133-5Suche in Google Scholar

3. CLSI. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline – third edition. CLSI document EP28 – A3c ed: Wayne, PA, USA: CLSI (Clinical Laboratory Standards Institute), 2010.Suche in Google Scholar

4. Rustad P, Felding P, Franzson L, Kairisto V, Lahti A, Martensson A, et al. The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties. Scand J Clin Lab Invest 2004;64: 271–84.10.1080/00365510410006324Suche in Google Scholar PubMed

5. Bakan E, Polat H, Ozarda Y, Ozturk N, Baygutalp NK, Umudum FZ, et al. A reference interval study for common biochemical analytes in Eastern Turkey: a comparison of a reference population with laboratory data mining. Biochem Med (Zagreb) 2016;26:210–23.10.11613/BM.2016.023Suche in Google Scholar PubMed PubMed Central

6. Bock BJ, Dolan CT, Miller GC, Fitter WF, Hartsell BD, Crowson AN, et al. The data warehouse as a foundation for population-based reference intervals. Am J Clin Pathol 2003;120:662–70.10.1309/W8J85AG4WDG6JGJ9Suche in Google Scholar

7. Grossi E, Colombo R, Cavuto S, Franzini C. The REALAB project: a new method for the formulation of reference intervals based on current data. Clin Chem 2005;51:1232–40.10.1373/clinchem.2005.047787Suche in Google Scholar PubMed

8. Tozzoli R, Giavarina D, Villalta D, Soffiati G, Bizzaro N. Definition of reference limits for autoantibodies to thyroid peroxidase and thyroglobulin in a large population of outpatients using an indirect method based on current data. Arch Pathol Lab Med 2008;132:1924–8.10.5858/132.12.1924Suche in Google Scholar PubMed

9. Katayev A, Balciza C, Seccombe DW. Establishing reference intervals for clinical laboratory test results: is there a better way? Am J Clin Pathol 2010;133:180–6.10.1309/AJCPN5BMTSF1CDYPSuche in Google Scholar PubMed

10. Pedersen MM, Ornemark U, Rustad P, Steensland H, Loikkanen M, Olafsdottir E, et al. The Nordic Trueness Project 2002: use of reference measurement procedure values in a general clinical chemistry survey. Scand J Clin Lab Invest 2004;64:309–20.10.1080/00365510410002805Suche in Google Scholar PubMed

11. Rustad P. Evaluation spreadsheet for X. Available at: http://nyenga.net/norip/X/x.htm. Accessed: 24 May 2017.Suche in Google Scholar

12. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502.10.1093/clinchem/18.6.499Suche in Google Scholar

13. Horn PS, Feng L, Li Y, Pesce AJ. Effect of outliers and nonhealthy individuals on reference interval estimation. Clin Chem 2001;47:2137–45.10.1093/clinchem/47.12.2137Suche in Google Scholar

14. Bjerner J, Theodorsson E, Hovig E, Kallner A. Non-parametric estimation of reference intervals in small non-Gaussian sample sets. Accredit Qual Assur 2009;14:185–92.10.1007/s00769-009-0490-2Suche in Google Scholar

15. Solberg HE. The IFCC recommendation on estimation of reference intervals. The RefVal program. Clin Chem Lab Med 2004;42:710–4.10.1515/CCLM.2004.121Suche in Google Scholar PubMed

16. Fraser CG, Hyltoft Petersen P, Libeer JC, Ricos C. Proposals for setting generally applicable quality goals solely based on biology. Ann Clin Biochem 1997;34:8–12.10.1177/000456329703400103Suche in Google Scholar PubMed

17. Christensen PA. Reference intervals for the P-Albumin bromocresol purple method. Scand J Clin Lab Invest 2017;77:472–6.10.1080/00365513.2017.1337217Suche in Google Scholar PubMed

18. Henriksen LO, Faber NR, Moller MF, Nexo E, Hansen AB. Stability of 35 biochemical and immunological routine tests after 10 hours storage and transport of human whole blood at 21 degrees C. Scand J Clin Lab Invest 2014;74:603–10.10.3109/00365513.2014.928940Suche in Google Scholar PubMed PubMed Central

19. Ricos C. Desirable biological variation database specifications. Available at: http://www.westgard.com/biodatabase1.htm. Accessed: 24 May 2017.Suche in Google Scholar

20. Warnick GR, Nauck M, Rifai N. Evolution of methods for measurement of HDL-cholesterol: from ultracentrifugation to homogeneous assays. Clin Chem 2001;47:1579–96.10.1093/clinchem/47.9.1579Suche in Google Scholar

21. Haeckel R, Wosniok W, Arzideh F, Zierk J, Gurr E, Streichert T. Critical comments to a recent EFLM recommendation for the review of reference intervals. Clin Chem Lab Med 2017;55:341–7.10.1515/cclm-2016-1112Suche in Google Scholar PubMed

22. Henny J, Vassault A, Boursier G, Vukasovic I, Mesko Brguljan P, Lohmander M, et al. Recommendation for the review of biological reference intervals in medical laboratories. Clin Chem Lab Med 2016;54:1893–900.10.1515/cclm-2016-0793Suche in Google Scholar PubMed

Received: 2017-6-30
Accepted: 2017-8-23
Published Online: 2017-10-14
Published in Print: 2018-2-23

©2018 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial
  3. Analytical quality: an unfinished journey
  4. Reviews
  5. Update in diagnosis and management of primary aldosteronism
  6. Diagnosis biomarkers in acute intestinal ischemic injury: so close, yet so far
  7. Opinion Papers
  8. Irregular analytical errors in diagnostic testing – a novel concept
  9. A Black Swan in clinical laboratory practice: the analytical error due to interferences in immunoassay methods
  10. General Clinical Chemistry and Laboratory Medicine
  11. Reaching consensus on communication of critical laboratory results using a collective intelligence method
  12. Stability of routine biochemical analytes in whole blood and plasma/serum: focus on potassium stability from lithium heparin
  13. GFR estimation based on standardized creatinine and cystatin C: a European multicenter analysis in older adults
  14. Binding of bromocresol green and bromocresol purple to albumin in hemodialysis patients
  15. Interlaboratory variability of urinary iodine measurements
  16. The venous thromboembolic risk and the clot wave analysis: a useful relationship?
  17. Hematology and Coagulation
  18. Autovalidation and automation of the postanalytical phase of routine hematology and coagulation analyses in a university hospital laboratory
  19. Reference Values and Biological Variations
  20. Indirect method for validating transference of reference intervals
  21. Differences in levels of albumin, ALT, AST, γ-GT and creatinine in frail, moderately healthy and healthy elderly individuals
  22. Cancer Diagnostics
  23. Serum exosomal hnRNPH1 mRNA as a novel marker for hepatocellular carcinoma
  24. Intragenic hypomethylation of DNMT3A in patients with myelodysplastic syndrome
  25. Cardiovascular Diseases
  26. Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin I
  27. MEF2C loss-of-function mutation associated with familial dilated cardiomyopathy
  28. Letter to the Editor
  29. Hyperuricemia does not seem to be an independent risk factor for coronary heart disease
  30. Reply to: Hyperuricemia does not seem to be an independent risk factor for coronary heart disease
  31. Preanalytics of ammonia: stability, transport and temperature of centrifugation
  32. Influence of delayed separation of plasma from whole blood on Cu, I, Mn, Se, and Zn plasma concentrations
  33. Copeptin as a diagnostic and prognostic biomarker in patients admitted to Emergency Department with syncope, presyncope and vertiginous syndrome
  34. Development of an internally controlled quantitative PCR to measure total cell-associated HIV-1 DNA in blood
  35. Selective changes in cholesterol metabolite levels in plasma of breast cancer patients after tumor removal
  36. Athletes beware before throwing towels to audiences
Heruntergeladen am 4.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2017-0574/html?lang=de
Button zum nach oben scrollen